VEGFA and diabetic retinopathy: Early use of anti-VEGF drugs in patients with diabetic retinopathy can significantly improve the fundus lesions, decrease the IOP and CRT, reduce the number of retinal microaneurysms, and improve the BCVA of the patients, with high clinical efficacy.